Practical Considerations for Clinicians When adding GLP1s to a liver-focused treatment plan: Evaluate contraindications (e.g., history of medullary thyroid cancer) Educate patients about common side effects and gradual dose titration Use liver biomarkers and imaging to monitor response over time Ensure cost and access considerations are addressed up front For additional guidance, consult Healthcare.pro or professional society recommendations to stay current on metabolic liver disease management
The appetite-suppressing effects of semaglutide can be felt even at the lowest doses
With long-acting GLP-1 receptor agonists, the gastric-emptying effect may lessen over time, though appetite suppression and other metabolic benefits typically persist
Everyone in the GLP-1 community is welcome creators and non-creators alike, whether you're just starting, well along the way, or in maintenance
Study inclusion criteria were (1) original clinical studies reporting in vivo GSH levels in the brain, serum, plasma, or blood cells (2)